<code id='EDA75B6B4C'></code><style id='EDA75B6B4C'></style>
    • <acronym id='EDA75B6B4C'></acronym>
      <center id='EDA75B6B4C'><center id='EDA75B6B4C'><tfoot id='EDA75B6B4C'></tfoot></center><abbr id='EDA75B6B4C'><dir id='EDA75B6B4C'><tfoot id='EDA75B6B4C'></tfoot><noframes id='EDA75B6B4C'>

    • <optgroup id='EDA75B6B4C'><strike id='EDA75B6B4C'><sup id='EDA75B6B4C'></sup></strike><code id='EDA75B6B4C'></code></optgroup>
        1. <b id='EDA75B6B4C'><label id='EDA75B6B4C'><select id='EDA75B6B4C'><dt id='EDA75B6B4C'><span id='EDA75B6B4C'></span></dt></select></label></b><u id='EDA75B6B4C'></u>
          <i id='EDA75B6B4C'><strike id='EDA75B6B4C'><tt id='EDA75B6B4C'><pre id='EDA75B6B4C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:8638
          Bristol Myers Squibb sign
          Courtesy Bristol Myers Squibb

          Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

          RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

          advertisement

          Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          As a primary care physician, here's how I hope to partner with AI
          As a primary care physician, here's how I hope to partner with AI

          AdobeIambothexcitedandterrifiedbytheentranceofartificialintelligenceintomyprimarycarepractice.AI’sen

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          Stanford updates investigation of president’s past research

          PeoplewalkonthecampusatStanfordUniversityinStanford,Calif.JeffChiu/APAninvestigationbyaspecialcommit